BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8635154)

  • 1. L-myc, GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers.
    Hsieh LL; Huang RC; Yu MW; Chen CJ; Liaw YF
    Cancer Lett; 1996 Jun; 103(2):171-6. PubMed ID: 8635154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma.
    Chen CJ; Yu MW; Liaw YF; Wang LW; Chiamprasert S; Matin F; Hirvonen A; Bell DA; Santella RM
    Am J Hum Genet; 1996 Jul; 59(1):128-34. PubMed ID: 8659516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India.
    Kiran M; Chawla YK; Kaur J
    DNA Cell Biol; 2008 Dec; 27(12):687-94. PubMed ID: 18816171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan.
    Sun CA; Wang LY; Chen CJ; Lu SN; You SL; Wang LW; Wang Q; Wu DM; Santella RM
    Carcinogenesis; 2001 Aug; 22(8):1289-94. PubMed ID: 11470760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects.
    Yu MW; Chiu YH; Chiang YC; Chen CH; Lee TH; Santella RM; Chern HD; Liaw YF; Chen CJ
    Am J Epidemiol; 1999 Apr; 149(7):621-9. PubMed ID: 10192309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of Glutathione S-Transferase Omega Gene Polymorphism with Different Stages of HBV Infection Including Hepatocellular Carcinoma in the Egyptian Population.
    Shaban NZ; Salem HH; Elsadany MA; Ali BA; Hassona EM; Mogahed FA
    Asian Pac J Cancer Prev; 2016; 17(4):2145-50. PubMed ID: 27221910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma.
    Yu MW; Yang SY; Pan IJ; Lin CL; Liu CJ; Liaw YF; Lin SM; Chen PJ; Lee SD; Chen CJ
    J Natl Cancer Inst; 2003 Oct; 95(19):1485-8. PubMed ID: 14519756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of genetic polymorphisms in glutathione S-transferases M1 with hepatitis beta-related hepatocellular carcinoma].
    Zhu MH; Chen XH; Zhou LF
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 34(2):126-30. PubMed ID: 15812885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
    Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study.
    Gelatti U; Covolo L; Talamini R; Tagger A; Barbone F; Martelli C; Cremaschini F; Franceschi S; Ribero ML; Garte S; Nardi G; Donadon V; Donato F
    Int J Cancer; 2005 Jun; 115(2):301-6. PubMed ID: 15688397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma.
    Yu MW; Gladek-Yarborough A; Chiamprasert S; Santella RM; Liaw YF; Chen CJ
    Gastroenterology; 1995 Oct; 109(4):1266-73. PubMed ID: 7557094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy).
    Covolo L; Gelatti U; Talamini R; Garte S; Trevisi P; Franceschi S; Franceschini M; Barbone F; Tagger A; Ribero ML; Parrinello G; Donadon V; Nardi G; Donato F
    Cancer Causes Control; 2005 Sep; 16(7):831-8. PubMed ID: 16132793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1.
    Chen SY; Chen CJ; Tsai WY; Ahsan H; Liu TY; Lin JT; Santella RM
    Nutr Cancer; 2000; 38(2):179-85. PubMed ID: 11525595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
    Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
    Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
    Han X; Xing Q; Li Y; Sun J; Ji H; Huazheng P; Jun L
    Hepatogastroenterology; 2012 Oct; 59(119):2285-9. PubMed ID: 22456434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene deletion of glutathione S-transferase M1 and T1 and risk factors of hepatocellular carcinoma in Egyptian patients.
    Abd El-Moneim E; Younis FA; Allam N; Gameel K; Osman M
    Egypt J Immunol; 2008; 15(2):125-34. PubMed ID: 20306695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.
    Yu MW; Chiu YH; Yang SY; Santella RM; Chern HD; Liaw YF; Chen CJ
    Br J Cancer; 1999 May; 80(3-4):598-603. PubMed ID: 10408872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of major histocompatibility complex class II genes in hepatocellular carcinoma.
    Li PK; Leung NW; Poon AS; Wong KC; Chan TH; Lai KN
    Dig Dis Sci; 1995 Jul; 40(7):1542-6. PubMed ID: 7628281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-myc proto-oncogene alleles and susceptibility to hepatocellular carcinoma.
    Taylor JA; Bell DA; Nagorney D
    Int J Cancer; 1993 Jul; 54(6):927-30. PubMed ID: 8392982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
    Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.